Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:37.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a site-wide revision note (Revision: v3.3.3) and removed the HHS Vulnerability Disclosure link along with Revision: v3.3.2; these are UI/policy updates and do not alter the clinical trial record data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:59:16.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:45.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and revision: v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T13:43:19.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The government funding/status notice banner was removed from the page, and it does not affect the trial record or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:28:27.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-11-03T01:10:31.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.